[Cardiovascular system research at the Institute of Drug Research]

Acta Pharm Hung. 2001;71(1):67-72.
[Article in Hungarian]

Abstract

The most significant achievements in the cardiovascular research areas have been reviewed. Among the beta-adrenoceptor blockers, antihypertensive, positive inotropic, and antiarrhythmic compounds synthesized and investigated at the IDR, a number of new drug candidates have been found and studied in clinical phases. One compound has been marketed (Tobanum, beta-adrenoceptor blocker).

Publication types

  • English Abstract

MeSH terms

  • Academies and Institutes
  • Adrenergic beta-Antagonists / chemical synthesis
  • Anti-Arrhythmia Agents / chemical synthesis
  • Antihypertensive Agents / chemical synthesis
  • Cardiotonic Agents / chemical synthesis
  • Cardiovascular Agents / chemical synthesis*
  • Cardiovascular Agents / chemistry
  • Drug Industry / trends
  • Hungary
  • Molecular Structure
  • Research / trends

Substances

  • Adrenergic beta-Antagonists
  • Anti-Arrhythmia Agents
  • Antihypertensive Agents
  • Cardiotonic Agents
  • Cardiovascular Agents